Development, Execution and Acceptance of a Manualized Dance/Movement Therapy Treatment Protocol for the Clinical Trial in the Treatment of Negative Symptoms and Psychosocial Functioning in Schizophrenia

被引:0
|
作者
Karolina Bryl
Sherry Goodill
机构
[1] College of Nursing and Health Professions,Department of Creative Arts Therapies
[2] Drexel University,undefined
来源
American Journal of Dance Therapy | 2020年 / 42卷
关键词
Dance/movement therapy; Manualized treatment protocol; Intervention manual; Schizophrenia; Negative symptoms; Psychosocial functioning;
D O I
暂无
中图分类号
学科分类号
摘要
The use of manual-based interventions that aim to improve outcomes and that allow for replication become a research standard in recent years. Currently, the dance/movement therapy English language literature contains few if any works on specific guidelines or models to help researchers conceptualize, develop, pilot, revise and execute treatment protocols. Therefore, this manuscript describes in detail the development of manualized dance/movement therapy treatment protocol for a clinical trial on the negative symptoms and psychosocial functioning in individuals with schizophrenia. It provides a comprehensive description of the step-by-step process of the creation and implementation of the intervention manual. As such it offers a guideline to help researchers conceptualize, develop, pilot, revise and execute the treatment protocol. Feasibility and acceptance findings are included. Discussion of the importance of the use of manualized treatment protocols in dance/movement therapy research and their limitations follows.
引用
收藏
页码:150 / 175
页数:25
相关论文
共 50 条
  • [1] Development, Execution and Acceptance of a Manualized Dance/Movement Therapy Treatment Protocol for the Clinical Trial in the Treatment of Negative Symptoms and Psychosocial Functioning in Schizophrenia
    Bryl, Karolina
    Goodill, Sherry
    AMERICAN JOURNAL OF DANCE THERAPY, 2020, 42 (02) : 150 - 175
  • [2] Negative symptoms and psychosocial functioning in schizophrenia: Neglected but important targets for treatment
    Hunter, R.
    Barry, S.
    EUROPEAN PSYCHIATRY, 2012, 27 (06) : 432 - 436
  • [3] The role of dance/movement therapy in the treatment of negative symptoms in schizophrenia: a mixed methods pilot study
    Bryl, Karolina
    Bradt, Joke
    Cechnicki, Andrzej
    Fisher, Kathleen
    Sossin, K. Mark
    Goodill, Sharon
    JOURNAL OF MENTAL HEALTH, 2022, 31 (05) : 613 - 623
  • [4] Single-Session Dance/Movement Therapy for People with Acute Schizophrenia: Development of a Treatment Protocol
    Biondo, Jacelyn
    Gerber, Nancy
    AMERICAN JOURNAL OF DANCE THERAPY, 2020, 42 (02) : 277 - 295
  • [5] Single-Session Dance/Movement Therapy for People with Acute Schizophrenia: Development of a Treatment Protocol
    Jacelyn Biondo
    Nancy Gerber
    American Journal of Dance Therapy, 2020, 42 : 277 - 295
  • [6] Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
    Alphs, Larry
    Panagides, John
    Lancaster, Scott
    PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (02) : 41 - 53
  • [7] Treatment acceptance and therapeutic relationship in the early stage of cognitive behavioral therapy on negative symptoms of schizophrenia
    Wittorf, A.
    Weber, R.
    Herrlich, J.
    Wiedemann, G.
    Woelwer, W.
    Buchkremer, G.
    Klingberg, S.
    NERVENHEILKUNDE, 2008, 27 (11) : 1007 - +
  • [8] Efficacy of Low-dose Olanzapine in Combination with Sertraline on Negative Symptoms and Psychosocial Functioning in Schizophrenia: A Randomized Controlled Trial
    Xiu, Meihong
    Zhao, Lei
    Sun, Qianqian
    Lang, Xiaoe
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (08) : 1406 - 1413
  • [9] A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia
    Buchanan, Robert W.
    Kelly, Deanna L.
    Weiner, Elaine
    Gold, James M.
    Strauss, Gregory P.
    Koola, Maju M.
    McMahon, Robert P.
    Carpenter, William T.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (04) : 394 - 400
  • [10] A Phase 3 Trial of Roluperidone, a Drug for the Treatment of Negative Symptoms in Schizophrenia
    Davidson, Michael
    Saoud, Jay
    Staner, Corinne
    Luthringer, Remy
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 366 - 366